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Protein phosphatasc type- 1 (PP. 1) has a protease resistant catalytic core M, = 35000 (PP-35K) and a carboxyl terminal segment which affects activity 
with various substrates. We found that micromolar concentration of a synthetic peptide, corresponding to residues 3 12-326 of the PP-I carboxyl 
terminus (P312-326) that is missing from BP-35K, increased the phosphatase activity of BP-3SK with phosphorylase and myosin light chains as 
substrates by decreasing the apparent Km without a change in V,,,. Purified PP-1 and BP-35K were inhibited identically by okadaic acid, but peptide 
P312-326 only stimulated the activity of PP-3SK. not full-length PP-1. Other peptides corresponding to the carboxyl terminus of phosphatase-2A 
or to the amino terminus of PP.1 did not affect the activity of PP-35K. A sequence conserved in PP-I from different species, Pro-Ilc-Thr-&o-Pro 
was implicated as the active region because a derivative peptide. Ala-Pro-Ile-Thr-Pro-Pro-Ala, stimulated the activity of PP-35K to the same extent 
as peptide P312-326 although at higher concentrations. These results indicate that the carboxyl terminus of PP-I interacts with the catalytic core 
to modulate its activity, and suggest hat the physiological regulation of PP-1 may involve this segment. 
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1. INTRODUCTION 
Of the four major cytosolic protein phosphatases in- 
volved in cellular regulation, types 1 and 2A are the 
primary regulators of metabolism [l]. In the past few 
years, cDNA clones for type-l and type-2A phos- 
phatases have been isolated and sequenced [2-91. The 
sequence for the catalytic subunit of protein phos- 
phatase type-l is comprised of 330 amino acids and 
predicts an Mr of 39.4 K [7,9]. Comparison of the 
type-l and type-2A sequences reveals that the two phos- 
phatases have about 50% amino acid sequence identity. 
The available sequences reveal consensus segments that 
are likely to be functional regions of the phosphatase 
[6]. However, the carboxyl terminal segments, unlike 
the rest of the structure, show no identity between 
type-l and type-2A phosphatases. 
the apocryphal belief that digestion removes a segment 
at the carboxyl terminus was confirmed. Synthetic pep- 
tides corresponding to only part of the carboxyl ter- 
minus of PP-1 interact with PP-35K and cause an in- 
crease in activity. Based on these results, we propose 
that the ‘tail’ of PP-1 binds to a specific site on the 
PP-35K fragment and modulates substrate interactions. 
2. EXPERIMENTAL 
2. I . Ma&rials 
The catalytic subunit of PP-1’ (Mr 38 000) can be 
converted to a catalytic fragment, PP-35K (Mr 35 000) 
by trypsin digestion in the presence of divalent metal 
[10-I 21 with an increase in phosphorylase phosphatase 
activity. It has been established that metal ion is respon- 
sible for the activation [13]. Digestion by chymotrypsin 
[14] has the same effect. Using anti-peptide antibodies, 
Phosphorylase b was purified according to Fischer and Krebs [IS] 
and converted to phosphorylase u [16]. Glycogen synthase was 
isolated from rabbit liver [17]. Myosin light chains were isolated from 
turkey gizzard [ 181 and phosphorylated by the CAMP-dependent pro- 
tein kinase, which phosphorylates the same site as myosin light chain 
kinase [19]. MOPS, PMSF, try>sin, and lima bean trypsin inhibitor 
were purchased from Sigma. Okadaic acid was from Moana 
Bioproducts. ‘251-Protein A and [y-“P]ATP were purchased from 
Dupont-New England Nuclear. Prestained molecular weight stan- 
dards for electrophoresis were obtained from Diversified Biotech. 
Other chemicals were purchased from Fisher Scientific. 
2.2. Methods 
Abbreviu~krrs: PP-I, catalytic subunit of type-l protein phosphatase; 
PP-35K, protease resistant catalytic fragment of PP-1; MOPS, 3-(N- 
morpholino)-propanesulfonic acid; DTT, dithiothreitol; PMSF, 
phenylmethylsulfonyl fluoride 
2.2. I. Preparation of type-l protein phosphatase 
The catalytic subunit of type-l phosphatasc was isolated essentially 
asdescribed previously [20] for preparation of thecatalytic fragment, 
but with modifications to be described elsewhere’. The preparations 
were determined to be type-l phosphatase by their sensitivity to 
phosphatase inhibitor-2 and reactivity with anti-(type- I phosphatase) 
antibodies detected on immunoblots [21]. The purified proteins had 
specific activities of 8000-12 000 U/mg for the catalytic subunit and 
20 000-30 000 U/me for the catalytic fragment. 
Corresporrderrce address: D.L. Brautigan, Section of Biochemistry, 
Division of Biology and Medicine, Brown University, Providence, RI 
02912. USA. 
2.2.2. Phosphatase assays 
Typically, phosphorylase phosphatase activity was assayed in 
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duplicate at 30°C as described [22]. Assays were also dune \ritli I! ‘I’]- 
phosphorylase u as substrate. Briefly, at specified time points, 10 pl 
of the reaction WC& spotted on Whatman 3MM filter papers and the 
papers were washed 3 times in cold 10% trichloroacetic acid for 10 
min and then twice with 95% ethanol for S min. The papers were dried 
and the amount of unreacted substrate remaining was quantified by 
liquid scintillation spectrometry. Glycogen synthase phosphatase ac- 
tivity was assayed according to a published procedure [23] using rab- 
bit liver glycogen synthase D as the substrate. The myosin light chain 
phosphatase activities of isolated PP-1 and PP-35K were measured 
with [“PJMLC (1 PM; 500-700 cpm/pmol) in standard assay buffer. 
After incubation at 30°C for 10 min, the reaction was stopped by 
spotting onto Whatman 3MM filter paper and processed as described 
with phosphorylase as substrate. Direct measurement of the effect of 
trypsin digestion on myosin light chain phosphatase activity of PP-1 
was done by the lab of Dr. David Hartshorne (Dept. of Musc!e 
Biology, Univ. of Arizona, Tucson, AZ) as described [24]. With both 
glycogen synthase and myosin light chains, trypsin was included at 10 
pg/ml. 
3. RESULTS AND DISCUSSION 
2.2.3. Peptide synthesis. 
The synthetic peptide. P312-326, with sequence, Leu-Asn-Pro-Gly- 
Gly-Arg-Pro-Be-Thr-Pro-Pro-Arg-Asn-Ser-Ala, was synthesized on 
the ABI 430A peptide synthesizer (Applied Biosystems, Inc.). 
Purification of the peptide was done on a Beckman 334 
chromatography system with a Hitachi model 100-40 detector at 220 
nm. The separation used VYDAC Crs (250 x 4,.ti mm) and CJ (250 
x 4.6 mm) reverse-phase columns with gradients of acetonitrile in 
0.1% trifluoroacetic acid. The amino acid composition of the purified 
peptide was confirmed with amino acid analysis using a Beckman 
model 7300 amino acid analyzer. Peptides corresponding to the 
amino terminus of PP-I, Ser-Asp-Ser-Glu-Lys-Leu-Asn-Leu-Asp- 
Ser; the carboxyl terminus of PP-2A. Arg-Gly-Glu-Pro-His-Val-Thr- 
Arg-Arg-Thr-Pro-Asp-Tyr-Phe-Lcu; and a derivative of P312-326, 
Ala-Pro-Be-Thr-Pro-Pro-Ala. were similarly synthesized, purified 
and analyzed. 
2.2.4. Stimulation by peptide 
The effect of peptides on PP-35K was determined by preincubating 
phosphatase (l-4 nM) with various concentrations of peptides in 20 
~1 for 10 min at 30°C followed by the addition of 20 pl phosphorylase 
a to initiate the phosphatase reaction. Phosphatase activity was deter- 
mined as described. The kinetic parameters of PP-35K plus or minus 
peptide P312-326 were determined with [“P]phosphorylasc a (IS-20 
cpm/pmol) as substrate, over the range of 6.4 to 32.0 pM. The 
amount of substrate present at time zero was quantified. A portion 
(10 11) of the reaction mixture was removed at 4, 8 and 12 min and the 
32P-substrate remaining was quantified by liquid scintillation spec- 
trometry as described. Initial velocities were determined, in duplicate, 
from linear plots of substrate remaining vs time. The kinetic constants 
were evaluated with the Michaelis-Menten equation using a BASIC 
program written for the IBM PC obtained from Dr. D. Quinn (Dept. 
of Chemistry, Univ. of Iowa. Iowa City, Iowa). 
3.1. Cotnpat-ison of PP-I md PP-35K 
Intact PP-1 catalytic subunit and the catalytic frag- 
ment, PP-35K, can be distinguished by functional pro- 
perties. PP-35K has increased phosphorylase 
phosphatase activity relative to PP-1 /lL,l%] (see Fig. 
1A). In contrast, purified PP-3% had much lower ac- 
tivity with myosin light chains than PP-1; 107 vs 319 
Wmg phosphatase, respectively (Fig. 1B). Protease 
digestion of PP-1 in situ decreased the myosin light 
chain phosphatase activity and resulted in an almost 
complete loss of glycogen synthase phosphatase activity 
in the absence of Mn2+ (33 vs 5 U/ml). The presence of 
Mn’ + mitigated the apparent loss of glycogen synthase 
phosphatase activity, but did not prevent it. PP-3% 
has been presumed to be PP-I lacking its cat-boxy1 ter- 
minus because both proteins are resistant to Edman 
degradation [29]. Mere we demonstrate that the dif- 
ference between PP-I and PP-35K is the loss of a 
carboxyl-terminal segment, Polycloncal antibodies to 
PP-35K [20] reacted with both PP-3% and intact PP-I 
as expected (Fig. 2, lanes a and b). In contrast, an- 
tibodies to peptides corresponding to PP-I residues 
3 12-326 (Martin et al., manuscript in preparation) or to 
residues 317-330 (Olivier et al., unpublished observa- 
tions) specifically reacted with PP-1 (38K) on im- 
munoblots, but were not reactive with the trypsin frag- 
ment, PP-35K (Fig. 2, lanes c and d). These results 
show that PP-35K is truncated at the sarboxyi terminus 
in the region including residues 312-330 of PP-I. 
Together, these results show that the carboxyl terminal 
region is not simply an autoinhibitory segment, like 
those found in several protein kinases [30], as was sug- 
gested for PP-1 by Tung et al. [l%J. The removal of an 
autoinhibitory domain can not account for the 
reciprocal changes in the activity of PPl with different 
substrates. 
Ahhough these enzymes were differentially active 
with different substrates, they did not demonstrate any 
PP.1 
PPGK 
2.2.5. Electrophoresis and immunoblotting PP.1 
Polyacrylatnide gel electrophoresis was performed according to 
Laemmli [25]. htmiunoblotting was done with the procedure of 
Burnette 1261 using affinity purified antibodies directed against the 
catalytic fragment of type-l phosphatase (2.5 p&/ml) and rabbit anti- 
sheep IgG as the secondary antibody [20]. Detection was accomplish- 
ed with [‘251]-Protein A exposed on Kodak XAR-5 film at -70°C 
with DuPont Cronex Hi-plus screens. 
PP-35K 
2.2.6. Protein determination 
Protein concentrations were determined by the Lowry procedure 
1271 or by the method of Bradford [28] using lysozyme as the stan- 
dard. 
Fig. 1. Activity of PP-1 and PP-3SK with different substrates. The 
specific activities of purified PP-1 (shaded bars) and PP-35K (open 
bars) with phosphorylase a and myosin light chains were compared 
using assays described in section 2. The values have been normalized 
to a value of 1 .O for PP- 1 that vvere 1 I 800 U/mg with phosphorylase 
u and 319 U/mg with myosin light chains. 
1 A Phospherytase  
I3 1 Myosln Light Chains 
I 
0.0 1 .o 2.0 
Rolatlvo gpeeiflc Actlvlty 
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a b d Table I 
Sequences of synthetic peptides 
Peptide Peptide sequence 
P312-326 L-N-P-G-G-R-P-I-T-P-P-R-N-S-A - 
A3 I&322A A-P-I-T-P-p-A 
Fig. 2. Western blotting of PP-I and PP3SK with polyclona! anti- 
PP-35K and site specific anti-carboxy! terminus peptide antibodies. 
SamrIGs (2 ,tg) of BP-1 (lanes a and c) and PP-35K (lanes b and d) 
were electrophoresed on a 12% dodecy! sulfate acrylamide gel and 
subsequently electrotransferred to a nitrocellulose filter. The filter 
was probed either with antibody to PP-3% (lanes a and b) or with an- 
tibody to synthetic peptide P3!2-326 corresponding to the carboxyl 
terminus of PP-I (lanes c and d). Subsequent detection was done with 
[‘*‘IJ-Protein A and autoradiography. Identical results were obtained 
with antibodies against another carboxyl terminal peptide composed 
of residues 317-330 (Olivier et a!., unpublished observations). 
difference in response to phosphatase inhibitors. Both 
PP-1 and PP-35K are inactivated in an identical time 
dependent reaction by the protein inhibitor-2 (not 
shown) and inhibited identically by the marine toxin, 
okadaic acid (Fig. 3) demonstrating that the carboxyl 
terminus is not involved in the binding of these in- 
hibitors. Furthermore, these results indicate that the 
carboxyl terminal segment must not be part of, nor oc- 
cupy, the catalytic site of PP-I. 
3.2. Effects of PP-I carboxyl-terminal peptides on 
PP-3% activity 
Addition of peptides corresponding to the missing 
carboxyl terminus selectively enhanced the activity of 
PP-35K, but not PP-1. The synthetic peptide cor- 
responding to residues 312-326 of PP-1 (P312-3X, 
Table I), stimulated the activity of PP-35K (tested with 
3 different preparations) up to 30% (Fig. 4). No in- 
crease in activity was observed with 0.01 PM P312-326 
(n = 3 independent trials). However, with 0.10 yM 
P312-326, there was a 2570 stimulation of activity 
(n = 6; P<O.Ol). At higher concentrations of 1.0 and 10 
100 
0 
0.0 1 .o 2.0 3.0 4.0 
LOQ [Okedolc Add (nM)J 
Fig. 4. Effects of various peptides on the phosphorylase phosphatase 
activity. From top to bottom: PP-35K alone(contro!; shaded) or with 
peptide P3!2-32G (10.0 PM) was incubated for IO min at 30°C and 
phosphatase activity determined with phosphorylase a or myosin light 
chains as described. The effect of peptides A3!8-322A (A3!!3-322A), 
PZ-IO (PP-I N TER), and P29S-309 (PPZA C TER) on PP-3SK activi- 
ty was tested at 10.0 bM peptidc. PP-I was incubated alone (control; 
shaded) or with peptide P3!2-326 (IO.0 PM) for IO min at 30°C. The 
activities are expressed as percent of control to normalize over multi- 
ple experiments with 3 different preparations of PP-3SK; for the ex- 
periments shown here the control activity was 0.80 ? 0.09 U/ml. An 
asterik (*) denotes a statistically significant difference from control 
Fig. 3. Inhibition of PP-I and PP-3SK by okadaic acid. The 
phosphorylase phosphatase activities of PP-I (closed squares) and 
PP-3SK (closedcircles) wereassayed in the presence of IO, SO, 100 and 
500 nM, and 5 and IO aM okadaic acid by measuring “Pi release from 
I”*P]phosphorylase a. Activities are prescntcd relative 10 a control 
reaction in the absence of okadaic acid. (Student’s r-test). 
PZ-IO S-D-S-E-K-L-N-L-Q-S 
P295-309 R-G-E-p-H-V-f-R-R-f-p-~-Y-~-L 
The sequences of pcptides tested as activators of PP-35K are 
presented in the single letter code: A, alacine; D, aspartic acid; F, 
phenylalanine; G, glycine; H, histidine; I, isoleucine; K, lysine; L, 
leucine; N, asparagine; P, proline; R, arginine; S, serine; T, 
threonine; V, valine; Y, tyrosine. 
PM P3 12-326, the same level of stimulation was observ- 
ed (n= 8; PcO.01) showing saturation by the peptide. 
Peptide P312-P326, at both 1 .O (n = 3) and 10 (n =3) 
PM (see Fig. 4), did not influence the activity of PP-I, 
with an intact carboxyl terminus. The lack of an effect 
with PP-1 under identical assay conditions also 
demonstrated that the effect of peptide was enzyme- 
directed, not a result of interaction with substrate. This 
conclusion was corroborated by the observation that 
activity of PP-35K, but not PP-1, also was stimulated 
30% with myosin light chains as substrate (Fig. 4; n = 3; 
PC 0.05). 
There was specificity not only for the phosphatase, 
but also for the peptide. Peptides corresponding to the 
carboxyl terminus of phosphatase-2A (P295-309, Table 
I) and the amino terminus of PP-1 (P2-10, Table I) did 
not substitute for P312-326 (Fig. 4; n =2). Therefore, 
the catalytic core of PP-1, with over 50% overall identi- 
ty to PP-2A and several regions of perfectly conserved 
0 50 100 150 200 
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sequences, was able to discriminate between the carbox- 
yl termini of PP-1 and PP-ZA and between the amino 
and carboxyl termini of PP-I. 
Within P312-326, the sequence, Arg-Pro-Ile-Thr- 
Pro-Pro-Arg, is conserved between rabbit and mouse 
PP-1 with a valine for isoleucine substitution as the only 
difference [31]. The sequence Thr-Pro-Pro is also pre- 
sent in the dis2+, the PP-1 gene in S. pombe [31]. A 
derivative of this sequence, Ala-Pro-Ile-Thr-Pro-Pro- 
Ala (A318-322A, Table I), also stimulated the 
phosphorylase phosphatase activity of PP-35K (Fig. 4). 
At 1 .O k&M A3 1 S-322A, there was no significant change 
in the activity of PP-34K (n = 3), compared to the same 
concentration of P312-P326 which caused maximal 
stimulation. However, 10 PM A31g-322A produced 
significant stimulation (n = 3; P< 0.05) of PP-35K up to 
the same level (Fig. 4) as $312-326 showing that both 
peptides saturated the response. Therefore, specific 
peptides stimulated PP-35K, but not intact PP-1, and 
the effect was selective for a sequence with multiple and 
vicinal yroliiic residues that is conserved between 
species. 
Kinetic analysis showed that the stimulatory effect of 
P312-P326 (10 PM) involved a decrease in the Km for 
phosphorylase without a change in V, (Fig. 5). In the 
absence of peptide P312-326, the value of Kn, was 19 Z!Z 
1.7 mM and in the presence of 10 PM peptide, the Km 
was 15 k 1.7 mM. Activity increased in the presence of 
peptide because of a decrease in Km for phosphorylase. 
Based on the K,,, in the presence of peptide P312-326, 
estimation of the predicted initial velocities predicts a 
20010 increase at 10 FM phosphorylase, consistent with 
the stimulation (20-30%) depicted in Fig. 4. The 
reciprocal changes in PP-I activity with different 
substrates found by Johansen and Ingebritsen after 
digestion with chymotrypsin predominantly involved 
increases in K,,, [ 141. These results implicate the carbox- 
yl terminus in regulating activity of the phosphatase. 
3.3. Role of the carboxyl-terminal domain 
How can both removal of the carboxyl terminus by 
digestion and its replacement with a synthetic peptide 
activate the phosphatase? The results can be explained 
by a model in which the carboxyl terminus interferes 
with metal ion activation of PP-1. Studies over the past 
20 years have demonstrated enhancement of 
phosphatase activity by MnZf [13,32-371 implicating a 
role for divalent metal in PP-I activity. Villa-Moruzzi 
et al. [13] have reported that isolated PP-1 is inactive 
unless divalent metal ion is added. Although we have 
isolated an active preparation of PP-1 without the addi- 
tion of exogenous metal, we find that in the presence of 
Mg’+, the activity of PP-1 and PP-35K was stabilized. 
McNall and Fischer [38] demonstrated that PP-1 activi- 
ty with phosphopeptide substrates required exposure of 
the enzyme to Mn2 + which increased in the order: 
heterodimcr of PP-1 and inhibitor-2 < catalytic 
Fig. 5. Effect of peptide P312-326 on PP-35K kinetics. As described 
in section 2, initial velocities were determined from time courses for 
the release of “Pi from phosphorylase in the absence (closed circles) 
and presence (closed squares) of 10 gM peptide P312-326. Other 
details of the data handling are in the text. Kinetic parameters were 
determined using a program written for the IBM PC by Dr. D. Quinn 
(Dept. of Chemistry, Univ. of Iowa, Iowa City, IA). The line shown 
was generated using the Graph program of Cricket software. 
subunit < trypsin-digested catalytic subunit. This is con- 
sistent with previous observations that trypsin plus 
Mn” ’ (or Co’+) affords the highest levels of PP-1 ac- 
tivity [lo]. Removal of the carboxyl-terminal segment 
would expose a site on the catalytic core of PP-1 for in- 
teraction with divalent metal ions that allowed expres- 
sion of the highest levels of Me2 +-dependent activity. 
Exposure of this site after digestion provides an ex- 
planation for the apparent conundrum that association 
of PP-35K with peptide segments is not just the reversal 
of protease digestion. 
The amino acid sequences from cDNA for PP-1 from 
Drosophila melanogaster [39] and Sacckaromyces 
cerevisiae [31] are both truncated at their carboxyl ter- 
mini, producing catalytic subunits which contain only 
the catalytic core, similar to PP-35K. Extracts from S. 
cerevisiae have unusually low phosphorylase 
phosphatase activity compared to extracts of mam- 
malian tissues, even when the activity was normalized 
to the level of &subunit specific phosphorylase kinase 
phosphatase (type-l) activity [40]. It will be interesting 
to determine the branch of the phylogenetic tree at 
which the sequence, Pro-Ile-Thr-Pro-Pro, is first pre- 
sent in the carboxyl terminus of PP-1. 
Regulation of activity and/or specificity of PP-1 in 
‘larger’ eukaryotes may involve modifications of the 
carboxyl terminus of PP-1. The active peptide segment, 
Pro-Ile-Thr-Pro-Pro, provides a potential 
phosphorylation site in the PP-1 catalytic subunit. 
Reportedly a brain phosphatase, recently classified as a 
type-3 phosphatase [41], is phosphorylated on 
threonine by protein kinase C [42]. We find that a pep- 
tide containing the core sequence and similar to 
P3 12-326 is phosphorylated by different protein kinases 
(Martin, B.L. et al., manuscript in preparation). The 
interaction of the carboxyl terminus with the catalytic 
core to, modulate activity may be influenced by its 
9 
phosphorylation state. It will be interesting to explore 
the possible regulation of PP-I by phosphorylation of 
its carboxyl terminal segment. 
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